Home/Accro Bioscience/Xiaohu (Jason) Zhang, Ph.D.
X(

Xiaohu (Jason) Zhang, Ph.D.

Co-founder & CEO

Accro Bioscience

Therapeutic Areas

Accro Bioscience Pipeline

DrugIndicationPhase
AC-201Moderate-to-Severe Plaque PsoriasisPhase 2
AC-101Ulcerative Colitis / Inflammatory Bowel DiseasePhase 1b
AC-003Acute Graft-Versus-Host Disease (aGVHD)Phase 1b